Perfil
Kristina Torfgård is currently Chief Executive Officer at IRLAB Therapeutics AB since 2024.
Formerly, Chief Executive Officer at Alzinova AB from 2019 to 2024.
Principal at AstraZeneca AB. Vice President-Clinical & Regulatory Affairs at Albireo Ltd. VP-Clinical, Regulatory Affairs & Global Project at Albireo AB from 2014 to 2017.
Vice President-Clinical & Regulatory Affairs at Albireo Pharma, Inc. from 2017 to 2019.
Education includes a doctorate from the University of Linköping.
Cargos activos de Kristina Torfgård
| Empresas | Cargo | Inicio |
|---|---|---|
| IRLAB THERAPEUTICS AB | Director Ejecutivo | 01/08/2024 |
Antiguos cargos conocidos de Kristina Torfgård.
| Empresas | Cargo | Fin |
|---|---|---|
| ALZINOVA AB | Director Ejecutivo | 31/07/2024 |
| ALBIREO PHARMA, INC. | Director Técnico/Científico/I+D | - |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Consejero General | 01/02/2017 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Consejero General | - |
Formación de Kristina Torfgård.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
Alzinova AB
Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
IRLAB Therapeutics AB
IRLAB Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for neurological diseases | Health Technology |
- Bolsa de valores
- Insiders
- Kristina Torfgård
















